Life Science Company News

Results 121 - 140 out of 500 displayed.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)

By: GlobeNewswire - 01 May 2024

Related companies: Palisade Bio, Inc.

Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)

By: GlobeNewswire - 01 May 2024

Related companies: Aileron Therapeutics, Inc.

Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024

By: GlobeNewswire - 01 May 2024

Related companies: Veru Inc.

Novo Nordisk A/S - share repurchase programme

By: GlobeNewswire - 01 May 2024

NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month

By: GlobeNewswire - 01 May 2024

Related companies: Neuronetics, Inc.

SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level

By: GlobeNewswire - 01 May 2024

Related companies: SELLAS Life Sciences Group, Inc.

Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million

By: GlobeNewswire - 01 May 2024

Related companies: Aileron Therapeutics, Inc.

Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation

By: GlobeNewswire - 01 May 2024

Related companies: Altamira Therapeutics Ltd.

SFWJ/MedCana Reacts to US DEA's Rescheduling of Marijuana

By: GlobeNewswire - 01 May 2024

WeightWatchers for Business and Personify Health Partner to Help Employers Address Weight Health Care

By: GlobeNewswire - 01 May 2024

Related companies: WW International, Inc.

Alkeus Pharmaceuticals Announces Presentation of Positive Gildeuretinol Data in Early-Stage Stargardt Patients During the ARVO 2024 Annual Meeting May 5-9

By: GlobeNewswire - 01 May 2024

Related companies: Alkeus Pharmaceuticals, Inc.

Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

By: GlobeNewswire - 01 May 2024

Related companies: Oncternal Therapeutics, Inc.

Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ

By: GlobeNewswire - 01 May 2024

Related companies: Cassava Sciences, Inc.

WAKE RADIOLOGY TEAM RALLIES TO SUPPORT TRIANGLE RACE FOR THE CURE

By: GlobeNewswire - 01 May 2024

Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone

By: GlobeNewswire - 01 May 2024

Related companies: Emergent BioSolutions Inc. | Erste Group Bank AG

Idorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bond

By: GlobeNewswire - 01 May 2024

Related companies: Idorsia Ltd

KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS

By: PR Newswire Association LLC. - 01 May 2024

Related companies: Kazia Therapeutics Limited

Perrigo Announces Quarterly Dividend

By: PR Newswire Association LLC. - 01 May 2024

Related companies: Perrigo Company plc.

OPTOMED RELEASES FIRST FDA-CLEARED HANDHELD AI FUNDUS CAMERA FOR DETECTION OF MORE THAN MILD DIABETIC RETINOPATHY

By: PR Newswire Association LLC. - 01 May 2024

INOVIO Reports Inducement Grants Under Inducement Plan

By: PR Newswire Association LLC. - 01 May 2024

Related companies: Inovio Pharmaceuticals, Inc.

Results 121 - 140 out of 500 displayed.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Enhance your business development with Biotechgate

Try for free »